suzetrigine 50 MG Oral Tablet

RxCUI: 2704833
RxNorm name: suzetrigine 50 MG Oral Tablet
Display name: suzetrigine 50 MG Oral Tablet
Full name: suzetrigine 50 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
JOURNAVX	SUZETRIGINE	Sportpharm LLC	d229cf71-96ec-4206-960b-d56fafc250ac	2026-07-21	Warnings, Adverse reactions	Exact identifier rxcui: 2704833
JOURNAVX	SUZETRIGINE	Vertex Pharmaceuticals Incorporated	f0976da4-1d20-4517-945c-b60ed2f41c12	2026-04-13	Warnings, Adverse reactions	Exact identifier rxcui: 2704833

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f0976da4-1d20-4517-945c-b60ed2f41c12	suzetrigine 50 MG Oral Tablet	SCD	9	These highlights do not include all the information needed to use JOURNAVX safely and effectively. See full prescribing information for JOURNAVX. JOURNAVX (suzetrigine) tablets, for oral use Initial U.S. Approval: 2025	20260413
f0976da4-1d20-4517-945c-b60ed2f41c12	suzetrigine 50 MG Oral Tablet	PSN	9	These highlights do not include all the information needed to use JOURNAVX safely and effectively. See full prescribing information for JOURNAVX. JOURNAVX (suzetrigine) tablets, for oral use Initial U.S. Approval: 2025	20260413